Status:
COMPLETED
Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)
Lead Sponsor:
Indivior Inc.
Conditions:
Opioid-Related Disorders
Opiate Dependence
Eligibility:
All Genders
15+ years
Brief Summary
The purpose of this study is to evaluate the acceptability and safety of switching to Suboxone® (buprenorphine plus naloxone) and the effect of the switch on medication dispensing. Subjects, for whom ...
Detailed Description
Nonprobability sampling was done by invitation to volunteer.
Eligibility Criteria
Inclusion
- All patients on substitution therapy, that are willing to switch to Suboxone, can be included.
- Therapeutic indications and contraindications for Suboxone® must be taken into consideration when selecting patients.
Exclusion
- According to product information
- In accordance with the product information pregnant women will be excluded.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
339 Patients enrolled
Trial Details
Trial ID
NCT00725608
Start Date
May 1 2008
End Date
April 1 2011
Last Update
March 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
(Multiple sites in Austria) => Coordinating CRO: H&P GmbH
Vienna, Austria, 1070